[Citrate (CG-120) therapy for urolithiasis. 1. Clinical effects]. 1988

T Ohkawa, and S Ebisuno, and S Morimoto, and S Yasukawa, and T Sonoda, and T Koide, and T Oka, and Y Aso, and E Higashihara, and R Kitagawa
Department of Urology, Wakayama Medical College.

Urinary citrate is an important determinant for crystallization of calcium salts, and recently oral administration of citrate has been suggested to be clinically useful in the management of renal stone disease. The effect of CG-120, a citrate compound (potassium citrate, sodium citrate and citric acid) produced by Dr. Madaus (Germany), on upper urinary tract stones was investigated in 398 patients in this study group. The patients were treated with 3 or 4 g CG-120 daily. Two hundred thirty-one of them were treated accurately according to the protocol of the study for more than 32 weeks. The cumulative percentage of positive clinical effect for the stone (disappearance, passage or decrease in size) was 30.3% (70/231). There were no differences in the clinical effect between the group of 3 g/day and the group of 4 g/day. CG-120 seemed to be more effective in the cases of ureteral stone, young patients and females, but was less effective in the recurrent stone formers. Although there were 45 episodes of side effects in 38 patients in this study, no serious side effects attributed to CG-120 were experienced. CG-120 was proved as a useful drug in the treatment of upper urinary tract calculi as well as its prevention.

UI MeSH Term Description Entries
D007669 Kidney Calculi Stones in the KIDNEY, usually formed in the urine-collecting area of the kidney (KIDNEY PELVIS). Their sizes vary and most contains CALCIUM OXALATE. Kidney Stones,Renal Calculi,Nephrolith,Renal Calculus,Calculi, Kidney,Calculi, Renal,Calculus, Kidney,Calculus, Renal,Kidney Calculus,Kidney Stone,Stone, Kidney,Stones, Kidney
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002951 Citrates Derivatives of CITRIC ACID.
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

T Ohkawa, and S Ebisuno, and S Morimoto, and S Yasukawa, and T Sonoda, and T Koide, and T Oka, and Y Aso, and E Higashihara, and R Kitagawa
September 1986, Hinyokika kiyo. Acta urologica Japonica,
T Ohkawa, and S Ebisuno, and S Morimoto, and S Yasukawa, and T Sonoda, and T Koide, and T Oka, and Y Aso, and E Higashihara, and R Kitagawa
April 1988, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
T Ohkawa, and S Ebisuno, and S Morimoto, and S Yasukawa, and T Sonoda, and T Koide, and T Oka, and Y Aso, and E Higashihara, and R Kitagawa
January 1986, Clinical therapeutics,
T Ohkawa, and S Ebisuno, and S Morimoto, and S Yasukawa, and T Sonoda, and T Koide, and T Oka, and Y Aso, and E Higashihara, and R Kitagawa
November 1999, Journal of endourology,
T Ohkawa, and S Ebisuno, and S Morimoto, and S Yasukawa, and T Sonoda, and T Koide, and T Oka, and Y Aso, and E Higashihara, and R Kitagawa
August 1967, Hinyokika kiyo. Acta urologica Japonica,
T Ohkawa, and S Ebisuno, and S Morimoto, and S Yasukawa, and T Sonoda, and T Koide, and T Oka, and Y Aso, and E Higashihara, and R Kitagawa
November 1987, Hinyokika kiyo. Acta urologica Japonica,
T Ohkawa, and S Ebisuno, and S Morimoto, and S Yasukawa, and T Sonoda, and T Koide, and T Oka, and Y Aso, and E Higashihara, and R Kitagawa
September 2013, The Kaohsiung journal of medical sciences,
T Ohkawa, and S Ebisuno, and S Morimoto, and S Yasukawa, and T Sonoda, and T Koide, and T Oka, and Y Aso, and E Higashihara, and R Kitagawa
August 1991, British journal of urology,
T Ohkawa, and S Ebisuno, and S Morimoto, and S Yasukawa, and T Sonoda, and T Koide, and T Oka, and Y Aso, and E Higashihara, and R Kitagawa
January 1969, Zeitschrift fur Urologie und Nephrologie,
T Ohkawa, and S Ebisuno, and S Morimoto, and S Yasukawa, and T Sonoda, and T Koide, and T Oka, and Y Aso, and E Higashihara, and R Kitagawa
January 1984, The Veterinary clinics of North America. Small animal practice,
Copied contents to your clipboard!